Mahon-Smith, Aoife http://orcid.org/0000-0003-1167-7693
Skingley, George http://orcid.org/0000-0002-7115-0394
Ayala-Nunes, Lara http://orcid.org/0000-0001-5070-7731
Batish, Anjali http://orcid.org/0000-0002-1008-9710
Sharp, Rosie http://orcid.org/0000-0002-4111-4181
Naujoks, Christel http://orcid.org/0000-0002-3799-6521
Schruf, Eva http://orcid.org/0000-0002-1412-5141
Compagno, Nicolò http://orcid.org/0000-0002-7590-4093
Moreno, Santiago G. http://orcid.org/0000-0002-6341-7546
Clinical trials referenced in this document:
Documents that mention this clinical trial
Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts
https://doi.org/10.1007/s13555-023-00968-2
Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus
https://doi.org/10.1007/s13555-023-00990-4
Article History
Received: 17 May 2023
Accepted: 19 July 2023
First Online: 5 October 2023
Declarations
:
: Christel Naujoks and Santiago G. Moreno are employees of Novartis Pharma AG at the time of performing the research and preparing the manuscript. Eva Schruf is an employee of Novartis Pharma GmbH at the time of performing the research and preparing the manuscript. Nicolò Compagno was an employee of Novartis Pharma AG at the time of performing the research and preparing the manuscript and is now an employee of F. Hoffmann-La Roche Ltd, Basel, Switzerland. Aoife Mahon-Smith, Lara Ayala, George Skingley and Rosie Sharp are employees of Adelphi Values Ltd., a health outcomes agency commissioned by Novartis Pharma AG to conduct this research. Anjali Batish was an employee of Adelphi Values at the time of performing the research and is now an employee of the National Institute for Health and Care Research (NIHR). The authors declare that there are no competing interests.
: All participants provided informed consent indicating their data will be used for medical research purposes and the study results may be published. The studies were performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Ethical approval and oversight for the clinical study, including exit interviews was obtained as part of clinical study procedures (clinicaltrials.gov ID: NCT04300296, EUDRACT: 2019-003588-24). The Western Copernicus Group Independent Review Board (WCG IRB), a centralized IRB, provided ethical approval and oversight to conduct the independent qualitative interviews in the US and Germany.